Department of Genetics, Instituto de Investigaciones Sanitarias - Fundacion Jiménez Díaz University Hospital (IIS-FJD-UAM), Madrid, Spain.
Centre for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, Madrid, Spain.
Sci Rep. 2018 Mar 27;8(1):5285. doi: 10.1038/s41598-018-23520-1.
Inherited syndromic retinopathies are a highly heterogeneous group of diseases that involve retinal anomalies and systemic manifestations. They include retinal ciliopathies, other well-defined clinical syndromes presenting with retinal alterations and cases of non-specific multisystemic diseases. The heterogeneity of these conditions makes molecular and clinical characterization of patients challenging in daily clinical practice. We explored the capacity of targeted resequencing and copy-number variation analysis to improve diagnosis of a heterogeneous cohort of 47 patients mainly comprising atypical cases that did not clearly fit a specific clinical diagnosis. Thirty-three likely pathogenic variants were identified in 18 genes (ABCC6, ALMS1, BBS1, BBS2, BBS12, CEP41, CEP290, IFT172, IFT27, MKKS, MYO7A, OTX2, PDZD7, PEX1, RPGRIP1, USH2A, VPS13B, and WDPCP). Molecular findings and additional clinical reassessments made it possible to accurately characterize 14 probands (30% of the total). Notably, clinical refinement of complex phenotypes was achieved in 4 cases, including 2 de novo OTX2-related syndromes, a novel phenotypic association for the ciliary CEP41 gene, and the co-existence of biallelic USH2A variants and a Koolen-de-Vries syndrome-related 17q21.31 microdeletion. We demonstrate that combining next-generation sequencing and CNV analysis is a comprehensive and useful approach to unravel the extensive phenotypic and genotypic complexity of inherited syndromic retinopathies.
遗传性综合征性视网膜病变是一组高度异质性的疾病,涉及视网膜异常和全身表现。它们包括视网膜纤毛病变、其他具有明确临床特征的视网膜改变和非特异性多系统疾病。这些疾病的异质性使得在日常临床实践中对患者进行分子和临床特征分析具有挑战性。我们探索了靶向重测序和拷贝数变异分析的能力,以提高对主要由不明确符合特定临床诊断的非典型病例组成的异质队列患者的诊断能力。在 18 个基因(ABCC6、ALMS1、BBS1、BBS2、BBS12、CEP41、CEP290、IFT172、IFT27、MKKS、MYO7A、OTX2、PDZD7、PEX1、RPGRIP1、USH2A、VPS13B 和 WDPCP)中发现了 33 个可能的致病性变异。分子发现和额外的临床重新评估使得能够准确描述 14 个先证者(总人数的 30%)。值得注意的是,在 4 个病例中实现了复杂表型的临床细化,包括 2 个新发性 OTX2 相关综合征、一个新的纤毛 CEP41 基因表型关联以及双等位基因 USH2A 变异和 Koolen-de-Vries 综合征相关 17q21.31 微缺失的共存。我们证明,将下一代测序和 CNV 分析相结合是一种全面而有用的方法,可以揭示遗传性综合征性视网膜病变广泛的表型和基因型复杂性。